The overarching goal of our project is to use IPSC derived cardiomyocytes from genotyped individuals as cellular models to investigate how human genetic variation influences the gene regulatory networks Involved In cardiac biology and disease. Despite current treatment regimens, cardiovascular diseases remain the leading cause of morbidity and mortality in the United States and developed countries. Genome-wide association studies have identified a number of loci associated with cardiovascular disease susceptibility. Our Study will clarify the functional significance of these findings by combining cellular reprogramming Strategies with integrated molecular profiling and cellular assays. We have assembled a team of highly accomplished researchers in stem cell biology, cardiac cell biology, genomics, molecular genetics/epigenetics, biostatistics, and clinical medicine, and are well positioned to achieve the project goals within five years. After collecting fibroblasts and keratinocytes from individuals in the UCSD TSP cohort, the project will be carried out in three phases. In PHASE I, we will establish standardized reagents and procedures for the generation of iPSCs. Additionally, we will take advantage of our ongoing research efforts to increase the efficiency of cardiomyocyte differentiation to 80%, a substantial increase over current protocols (~20%). In PHASE II, we will develop cutting-edge technologies for high throughput generation of IPSCs, which will enable us to generate 600 iPSC lines (3 lines each from 200 individuals) in ~ 24 months. We will also scale our optimized protocols for deriving cardiomyocytes from the IPSC lines. In PHASE III we will initially perform validation experiments to measure the genomic profile variability between isogenic (derived from the same individual) cardiomyocytes. We will then use the derived cardiomyocytes to 1) Identify and characterize the causal DNA variants underlying strong GWAS signals with electrocardiographic traits;and 2) Identify expressed quantitative traits loci (eQTL) in the cohort of IPSC derived cardiomyocytes at baseline (untreated) and after stimulation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL107442-02
Application #
8300829
Study Section
Special Emphasis Panel (ZHL1-CSR-N (F1))
Program Officer
Jaquish, Cashell E
Project Start
2011-07-15
Project End
2016-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
2
Fiscal Year
2012
Total Cost
$1,403,130
Indirect Cost
$177,228
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Pulecio, Julian; Nivet, Emmanuel; Sancho-Martinez, Ignacio et al. (2014) Conversion of human fibroblasts into monocyte-like progenitor cells. Stem Cells 32:2923-38
Aguirre, Aitor; Montserrat, Nuria; Zacchigna, Serena et al. (2014) In vivo activation of a conserved microRNA program induces mammalian heart regeneration. Cell Stem Cell 15:589-604
Liu, Guang-Hui; Suzuki, Keiichiro; Li, Mo et al. (2014) Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun 5:4330
Zhang, Kuixing; Deacon, Dekker C; Rao, Fangwen et al. (2014) Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected]. J Am Coll Cardiol 63:358-68
Morris, Rob; Sancho-Martinez, Ignacio; Sharpee, Tatyana O et al. (2014) Mathematical approaches to modeling development and reprogramming. Proc Natl Acad Sci U S A 111:5076-82
Gorkin, David U; Leung, Danny; Ren, Bing (2014) The 3D genome in transcriptional regulation and pluripotency. Cell Stem Cell 14:762-75
Sancho-Martinez, Ignacio; Ocampo, Alejandro; Izpisua Belmonte, Juan Carlos (2014) Reprogramming by lineage specifiers: blurring the lines between pluripotency and differentiation. Curr Opin Genet Dev 28:57-63
Suzuki, Keiichiro; Yu, Chang; Qu, Jing et al. (2014) Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. Cell Stem Cell 15:31-6
Yoshioka, Naohisa; Gros, Edwige; Li, Hai-Ri et al. (2013) Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 13:246-54
Xie, Wei; Ren, Bing (2013) Developmental biology. Enhancing pluripotency and lineage specification. Science 341:245-7

Showing the most recent 10 out of 11 publications